Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 2851 AL 2865

Clinical and functional outcomes of total hip arthroplasty in patients with cerebral palsy: A systematic review

Adams CT, Lakra A.

J Orthop. 2020 Jan 25;21:19-24. doi: 10.1016/j.jor.2020.01.031. eCollection 2020 Sep-Oct.

Efficacy and Safety of OnabotulinumtoxinA 400 Units in Patients with Post-Stroke Upper Limb Spasticity: Final Report of a Randomized, Double-Blind, Placebo-Controlled Trial with an Open-Label Extension Phase

Abo M, Shigematsu T, Hara H, Matsuda Y, Nimura A, Yamashita Y, Takahashi K.

Toxins (Basel). 2020 Feb 18;12(2):127. doi: 10.3390/toxins12020127.

[Future directions of stroke rehabilitation]

Kakuda W.

Rinsho Shinkeigaku. 2020 Mar 31;60(3):181-186. doi: 10.5692/clinicalneurol.cn-001399. Epub 2020 Feb 26.

Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Hemiparesis in Adults with Lower Limb Spasticity Previously Treated With Other Botulinum Toxins: A Secondary Analysis of a Randomized Controlled Trial

Esquenazi A, Stoquart G, Hedera P, Jacinto LJ, Dimanico U, Constant-Boyer F, Brashear A, Grandoulier AS, Vilain C, Picaut P, Gracies JM.

PM R. 2020 Sep;12(9):853-860. doi: 10.1002/pmrj.12348. Epub 2020 Mar 27.

Near-infrared spectroscopy as a quantitative spasticity assessment tool: A systematic review

McDougall J, Chow E, Harris RL, Mills PB.

J Neurol Sci. 2020 May 15;412:116729. doi: 10.1016/j.jns.2020.116729. Epub 2020 Feb 10.

Predictors of Nabiximols (Sativex(®)) discontinuation over long-term follow-up: a real-life study

Carotenuto A, Costabile T, De Lucia M, Moccia M, Falco F, Petruzzo M, De Angelis M, Russo CV, Saccà F, Lanzillo R, Brescia Morra V.

J Neurol. 2020 Jun;267(6):1737-1743. doi: 10.1007/s00415-020-09739-x. Epub 2020 Mar 2.

Alternative Methods for Testing Botulinum Toxin: Current Status and Future Perspectives

Nepal MR, Jeong TC.

Biomol Ther (Seoul). 2020 Jul 1;28(4):302-310. doi: 10.4062/biomolther.2019.200.

Neurogenic heterotopic ossification in Guillain-Barre syndrome: a rare case report

Nalbantoglu M, Tuncer OG, Acık ME, Matur Z, Altunrende B, Ozgonenel E, Ozgonenel L.

J Musculoskelet Neuronal Interact. 2020 Mar 3;20(1):160-164.

Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA

Fheodoroff K, Rekand T, Medeiros L, Koßmehl P, Wissel J, Bensmail D, Scheschonka A, Flatau-Baqué B, Simon O, Dressler D, Simpson DM.

Health Qual Life Outcomes. 2020 Mar 4;18(1):51. doi: 10.1186/s12955-020-01304-4.

Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review

Mecha M, Carrillo-Salinas FJ, Feliú A, Mestre L, Guaza C.

Front Cell Neurosci. 2020 Feb 19;14:34. doi: 10.3389/fncel.2020.00034. eCollection 2020.

Rosai-Dorfman disease with paravertebral and epidural thoracic spine involvement: A case report and literature review

Jayaram A, Al Maslamani NJ, Rahiman NAPA, Negi VC.

Radiol Case Rep. 2020 Feb 25;15(5):484-488. doi: 10.1016/j.radcr.2020.01.026. eCollection 2020 May.

IncobotulinumtoxinA for upper- and lower-limb spasticity in Japanese patients

Kagaya H, Masakado Y, Saitoh E, Fujiwara T, Abo M, Izumi SI, Nodera H, Dekundy A, Hiersemenzel R, Nalaskowski CM, Hanschmann A, Kaji R.

Curr Med Res Opin. 2020 May;36(5):827-834. doi: 10.1080/03007995.2020.1740187. Epub 2020 Mar 23.

A case report on intensive, robot-assisted rehabilitation program for brainstem radionecrosis

Tartamella F, Chillura A, Pisano MF, Cacioppo A, Licari S, Caradonna D, Portaro S, Calabrò RS, Bramanti P, Naro A.

Medicine (Baltimore). 2020 Mar;99(10):e19517. doi: 10.1097/MD.0000000000019517.

Management of Spasticity After Traumatic Brain Injury in Children

Enslin JMN, Rohlwink UK, Figaji A.

Front Neurol. 2020 Feb 21;11:126. doi: 10.3389/fneur.2020.00126. eCollection 2020.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias